37
Views
44
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Intra-S-Phase Checkpoint Activation by Direct CDK2 Inhibition

, , , , , & show all
Pages 6268-6277 | Received 13 Jan 2004, Accepted 29 Apr 2004, Published online: 27 Mar 2023

REFERENCES

  • Abraham, R. T. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2177–2196.
  • Akiyama, T., Ohuchi T., Sumida S., Matsumoto K., and Toyoshima K.. 1992. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA 89:7900–7904.
  • Bakkenist, C. J., and Kastan M. B.. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499–506.
  • Banin, S., Moyal L., Shieh S., Taya Y., Anderson C. W., Chessa L., Smorodinsky N. I., Prives C., Reiss Y., Shiloh Y., and Ziv Y.. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674–1677.
  • Berthet, C., Aleem E., Coppola V., Tessarollo L., and Kaldis P.. 2003. Cdk2 knockout mice are viable. Curr. Biol. 13:1775–1785.
  • Blasina, A., Price B. D., Turenne G. A., and McGowan C. H.. 1999. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9:1135–1138.
  • Blow, J. J., and Hodgson B.. 2002. Replication licensing—defining the proliferative state? Trends Cell Biol. 12:72–78.
  • Burma, S., Chen B. P., Murphy M., Kurimasa A., and Chen D. J.. 2001. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276:42462–42467.
  • Canman, C. E., Lim D. S., Cimprich K. A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M. B., and Siliciano J. D.. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677–1679.
  • Carney, J. P., Maser R. S., Olivares H., Davis E. M., Le Beau M., Yates III J. R., Hays L., Morgan W. F., and Petrini J. H.. 1998. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477–486.
  • Casper, A. M., Nghiem P., Arlt M. F., and Glover T. W.. 2002. ATR regulates fragile site stability. Cell 111:779–789.
  • Coverley, D., Laman H., and Laskey R. A.. 2002. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat. Cell Biol. 4:523–528.
  • D'Amours, D., and Jackson S. P.. 2002. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 3:317–327.
  • David-Pfeuty, T. 1999. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells. Oncogene 18:7409–7422.
  • el-Deiry, W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., and Vogelstein B.. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
  • Hall-Jackson, C. A., Cross D. A., Morrice N., Smythe C., Sarkaria J. N., Busby E. C., Tibbetts R. S., Roos P., Taya Y., Karnitz L. M., and Abraham R. T.. 1999. ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene 18:6707–6713.
  • Hardcastle, I. R., Golding B. T., and Griffin R. J.. 2002. Designing inhibitors of cyclin-dependent kinases. Annu. Rev. Pharmacol. Toxicol. 42:325–348.
  • Hinchcliffe, E. H., and Sluder G.. 2001. Centrosome duplication: three kinases come up a winner! Curr. Biol. 11:R698–R701.
  • Hu, B., Mitra J., van den Heuvel S., and Enders G. H.. 2001. S- and G2-phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Mol. Cell. Biol. 21:2755–2766.
  • Ishimi, Y., Komamura-Kohno Y., You Z., Omori A., and Kitagawa M.. 2000. Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2. J. Biol. Chem. 275:16235–16241.
  • Ishimi, Y., Komamura-Kohno Y., You Z., Omori A., and Kitagawa M.. 2001. Phosphorylation of Mcm4 at specific sites by cyclin-dependent kinase leads to loss of Mcm4,6,7 helicase activity. J. Biol. Chem. 276:34428–34433.
  • Kaur, G., Stetler-Stevenson M., Sebers S., Worland P., Sedlacek H., Myers C., Czech J., Naik R., and Sausville E.. 1992. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl. Cancer Inst. 84:1736–1740.
  • Kim, K. S., Kimball S. D., Misra R. N., Rawlins D. B., Hunt J. T., Xiao H. Y., Lu S., Qian L., Han W. C., Shan W., Mitt T., Cai Z. W., Poss M. A., Zhu H., Sack J. S., Tokarski J. S., Chang C. Y., Pavletich N., Kamath A., Humphreys W. G., Marathe P., Bursuker I., Kellar K. A., Roongta U., Batorsky R., Mulheron J. G., Bol D., Fairchild C. R., Lee F. Y., and Webster K. R.. 2002. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities. J. Med. Chem. 45:3905–3927.
  • Lanni, J. S., and Jacks T.. 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18:1055–1064.
  • Lei, M., and Tye B. K.. 2001. Initiating DNA synthesis: from recruiting to activating the MCM complex. J. Cell Sci. 114:1447–1454.
  • Ma, T., Van Tine B. A., Wei Y., Garrett M. D., Nelson D., Adams P. D., Wang J., Qin J., Chow L. T., and Harper J. W.. 2000. Cell cycle-regulated phosphorylation of p220NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev. 14:2298–2313.
  • Melo, J., and Toczyski D.. 2002. A unified view of the DNA-damage checkpoint. Curr. Opin. Cell Biol. 14:237–245.
  • Mihaylov, I. S., Kondo T., Jones L., Ryzhikov S., Tanaka J., Zheng J., Higa L. A., Minamino N., Cooley L., and Zhang H.. 2002. Control of DNA replication and chromosome ploidy by geminin and cyclin A. Mol. Cell. Biol. 22:1868–1880.
  • Mimura, S., and Takisawa H.. 1998. Xenopus Cdc45-dependent loading of DNA polymerase alpha onto chromatin under the control of S-phase Cdk. EMBO J. 17:5699–5707.
  • Ortega, S., Prieto I., Odajima J., Martin A., Dubus P., Sotillo R., Barbero J. L., Malumbres M., and Barbacid M.. 2003. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35:25–31.
  • Paull, T. T., Rogakou E. P., Yamazaki V., Kirchgessner C. U., Gellert M., and Bonner W. M.. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:886–895.
  • Pelizon, C. 2003. Down to the origin: Cdc6 protein and the competence to replicate. Trends Cell Biol. 13:110–113.
  • Pines, J. 1999. Four-dimensional control of the cell cycle. Nat. Cell Biol. 1:E73–E79.
  • Rhind, N., and Russell P.. 2000. Checkpoints: it takes more than time to heal some wounds. Curr. Biol. 10:R908–R911.
  • Rogakou, E. P., Pilch D. R., Orr A. H., Ivanova V. S., and Bonner W. M.. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858–5868.
  • Sarkaria, J. N., Busby E. C., Tibbetts R. S., Roos P., Taya Y., Karnitz L. M., and Abraham R. T.. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:4375–4382.
  • She, Q. B., Chen N., and Dong Z.. 2000. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275:20444–20449.
  • Shieh, S. Y., Ikeda M., Taya Y., and Prives C.. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334.
  • Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3:155–168.
  • Tauchi, H., Kobayashi J., Morishima K., van Gent D. C., Shiraishi T., Verkaik N. S., vanHeems D., Ito E., Nakamura A., Sonoda E., Takata M., Takeda S., Matsuura S., and Komatsu K.. 2002. Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 420:93–98.
  • Tetsu, O., and McCormick F.. 2003. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3:233–245.
  • Tibbetts, R. S., Brumbaugh K. M., Williams J. M., Sarkaria J. N., Cliby W. A., Shieh S. Y., Taya Y., Prives C., and Abraham R. T.. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152–157.
  • van den Heuvel, S., and Harlow E.. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054.
  • Vaziri, C., Saxena S., Jeon Y., Lee C., Murata K., Machida Y., Wagle N., Hwang D. S., and Dutta A.. 2003. A p53-dependent checkpoint pathway prevents rereplication. Mol. Cell 11:997–1008.
  • Vogelstein, B., Lane D., and Levine A. J.. 2000. Surfing the p53 network. Nature 408:307–310.
  • Walter, J. C. 2000. Evidence for sequential action of cdc7 and cdk2 protein kinases during initiation of DNA replication in Xenopus egg extracts. J. Biol. Chem. 275:39773–39778.
  • Ward, I. M., and Chen J.. 2001. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276:47759–47762.
  • Zhao, J., Kennedy B. K., Lawrence B. D., Barbie D. A., Matera A. G., Fletcher J. A., and Harlow E.. 2000. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 14:2283–2297.
  • Zhou, B. B., Chaturvedi P., Spring K., Scott S. P., Johanson R. A., Mishra R., Mattern M. R., Winkler J. D., and Khanna K. K.. 2000. Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275:10342–10348.
  • Zhou, B. B., and Elledge S. J.. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408:433–439.
  • Zou, L., and Elledge S. J.. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542–1548.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.